Marco Campitiello Selected Research

Marco Campitiello Research Topics

8	Neoplasms (Cancer) 01/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 12/2020 - 11/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2022
1	Hypochromic Anemia (Chlorosis) 10/2022
1	Melanoma (Melanoma, Malignant) 10/2022
1	Lymphatic Metastasis 11/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2018
1	Lymphadenopathy 06/2018
1	Colitis 06/2018
1	Subdural Hematoma (Subdural Hemorrhage) 06/2018
1	Pneumonia (Pneumonitis) 06/2018
1	Thrombocytopenia (Thrombopenia) 06/2018
1	Seminoma 06/2018
1	Myeloid Sarcoma (Chloroma) 06/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2017

2	Paclitaxel (Taxol)FDA LinkGeneric 08/2020 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 08/2020 - 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	NivolumabIBA 10/2022
1	Transaminases (Aminotransferases)IBA 10/2022
1	IpilimumabIBA 10/2022
1	pertuzumabIBA 12/2020
1	Trastuzumab (Herceptin)FDA Link 12/2020
1	Bevacizumab (Avastin)FDA Link 08/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	AutoantibodiesIBA 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019
1	Dihydrotachysterol (AT 10)IBA 12/2018
1	Chromogranin AIBA 12/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2018
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Everolimus FDA Link 01/2017
1	Axitinib (AG 013736)IBA 01/2017